Haemonetics HAE Fair value of previously held equity interest settled in connection with acquisition
Fair value of previously held equity interest settled in connection with acquisition at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept hae:FairValueOfPreviouslyHeldEquityInterestSettledInConnectionWithAcquisition.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's fair value of previously held equity interest settled in connection with acquisition.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's fair value of previously held equity interest settled in connection with acquisition?
- Haemonetics (HAE) reported fair value of previously held equity interest settled in connection with acquisition of $11.81M in Q1 2026.
- What does fair value of previously held equity interest settled in connection with acquisition mean?
- This metric quantifies the fair value adjustment of an equity interest held by the company in an entity prior to acquiring full control or a larger stake. It reflects the non-cash gain or loss recognized when the previously held interest is remeasured to fair value at the acquisition date. This is a critical indicator for investors to understand the accounting impact of step-acquisitions on the company's financial position.